![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.52 | 4.36 | 4.99 | - | 24,733 | 08:00:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/4/2020 12:27 | Mark, I cant see AZN mentioning any deals on Wed. when SNG are still in Phase II trials | ![]() 141jaffa | |
28/4/2020 12:20 | It is not a vaccine | ![]() dave444 | |
28/4/2020 12:18 | AstraZeneca reports first-quarter results on Wednesday, with analysts focused on the impact of the virus outbreak on the China business, which accounted for more than 30% of the U.K. drugmaker’s revenue in 2019. They’ll also look for comments on the potential of blood cancer drug Calquence and diabetes medicine Farxiga in treating Covid-19. Most expect the company to reiterate its full-year guidance for high single-digit to low double-digit sales. Fingers crossed there will be comments mentioning a new licensing deal with SNG | ![]() markinvestor | |
28/4/2020 12:08 | FWIW following on from what Richard said in the interview, I don't think they are close to completing recruitment. A week at least to go IMHO probably 2. | ![]() nobbygnome | |
28/4/2020 12:08 | thought remdesivir had flopped already though | ![]() d1nga | |
28/4/2020 12:07 | Dave444 hxxps://clinicaltria it would appear from the above link that SNG001 is in phase 2 | ![]() oscarino | |
28/4/2020 12:05 | Good point PDT. Some big block sells STILL going through. It seems never ending ! | ![]() peachie 74 | |
28/4/2020 11:54 | It is interesting to follow the approval process for Gilead's Remdesivir. So far its efficacy seems patchy yet it could fly through approval processes. If the bar is low then SNG only needs to show safety and some minor success to be in high demand. | ![]() pdt | |
28/4/2020 11:18 | My guess is that recruitment is just about completed so I think that will be announced any day. I am also expecting an update from Pharmaxis and the LOXL2 inhibitor. They should give a quarterly update on Thursday this week. | ![]() pdt | |
28/4/2020 11:06 | Bound to be May the 4th - be with you | ![]() toffeeman | |
28/4/2020 10:47 | Anyone contacted SNG as to releasing an update or is this going to be a may 1st or 4th job? | ![]() jonnynixon | |
28/4/2020 10:38 | Interestingly there are 119 vaccines development in progress for Covid19!110 are in preclinical 8 in Phase 11 in Phase 2 | ![]() dave444 | |
28/4/2020 10:21 | How predictable. | ![]() cambradjones | |
28/4/2020 09:58 | Added another 6k shared here. Waiting game for the big news to come | thwarnts | |
28/4/2020 09:58 | To those bored sellers chasing other stocks with the intention of getting back in later, the video below is reminder that there is interim potential news to be RNS'd. For example and all from the video: 1. In relation to the hospital trial RNS on 18 March they will 'give out data every so often to the Market' 2. It stated that 'very soon' they were to 'implement home based treatment' and were 'confident that this would start in the coming weeks'. New on this imminent. 3. It was stated that they were 'looking down the supply pipeline for the manufacture process'for delivery of drugs etc to make sure they are in a position to provide millions of doses around the world' . News could drop anytime on this issue also. | ![]() myst1 | |
28/4/2020 09:57 | Thanks Evertonian I just wondered if they could do some of the work in advance of the last patient or not. Back to sitting on my hands. | ![]() adman50 | |
28/4/2020 09:54 | Back level, now watch the sellers appear. | ![]() cambradjones | |
28/4/2020 09:48 | Seller done and this should now move very fast... No ramping but I think we'll have a RNS very soon, it was Richard that told us this after all! Blue we go and a special thank you for those who sold this morning allowing me to add more under 56p! One hour closer to news and who would risk not being in now.... Home trial news, fully recruited trial news, trial way ahead of expectations (schedule), collaboration with big pharma news..... Exciting!! | ![]() likya123 | |
28/4/2020 09:43 | Adman They will be collecting the regular results for each patient - but won't know whether the individual received SNG001 or the placebo. What they WILL do is predict on the basis of the on-going results which patients received SNG001. Let's hope they can see a significant difference.... | ![]() toffeeman | |
28/4/2020 09:40 | For the followers of DEMG, Turner Pope bought out a note yesterday saying that DEMG are a takeover target in the current situation because of their superior technology. The buying pressure seems to be mounting again... Back to SNG now. Good to see the reversal.... | ![]() nobbygnome | |
28/4/2020 09:40 | Nobody is everything unblinded at the end or if they have 50 patients data they could start reviewing now? | ![]() adman50 | |
28/4/2020 09:39 | I just picked up another 7600 shares. | ![]() dovey21 | |
28/4/2020 09:38 | Interesting start this morning with early shake and no sign of block seller with their 10k sells. Looking likely that seller has cleared and this will now move up sharply over coming trading days continuing in our upwards rising channel. | ![]() likya123 | |
28/4/2020 09:11 | Patience is a virtue! Probably another 4 weeks before the results so plenty of time for price increases ahead of that. Plus we will get some updates before then which should help the price; I can think of 3 possible announcements. The problem is the traders who want to make their £200 and move on to the next hot stock. That is not going to work with SNG.... | ![]() nobbygnome | |
28/4/2020 09:10 | News must be getting closer as trial results start to be reviewed | ![]() imjustdandy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions